All In Biotech

Free tool

FAERS Monitor: Xolair

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 103976 or its brand name (Xolair, Omalizumab). Reports on generic versions are filed under their own applications.

Reports

87,094

Serious

46,180

53% of reports

Hospitalization

15,984

Death reported

2,485

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • asthma12,359
  • urticaria11,739
  • no adverse event11,200
  • off label use11,096
  • dyspnoea10,547
  • drug ineffective8,624
  • cough7,188
  • pruritus6,575
  • fatigue6,263
  • malaise5,790
  • wheezing5,674
  • headache5,574
  • pneumonia5,462
  • pain4,566
  • anaphylactic reaction4,550

Reports by year received

View as table
YearReports
2004506
2005528
2006455
2007705
2008564
2009864
2010993
20111,196
20121,937
20131,613
20141,912
20152,180
20163,762
20177,651
20184,876
20195,460
20205,473
20215,295
20225,312
20235,719
202413,060
20259,846
20267,187

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,967,065 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
asthmaSignal12,35929.529.0305,015
wheezingSignal5,67425.424.8120,820
anaphylactic reactionSignal4,55021.620.982,146
urticariaSignal11,73918.117.8177,997
no adverse eventSignal11,20015.815.6147,406
coughSignal7,1886.36.231,828
dyspnoeaSignal10,5474.64.529,618
pruritusSignal6,5754.24.115,961
pneumoniaSignal5,4624.14.012,918
malaiseSignal5,7903.23.18,915
off label useSignal11,0963.13.016,123
headacheSignal5,5742.22.13,534
fatigue6,2632.01.92,986
pain4,5661.81.81,662
drug ineffective8,6241.61.61,968

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.